Evercore ISI Reiterates Buy Rating on Krystal Biotech (KRYS), Sets $218 PT

Krystal Biotech, Inc. (NASDAQ:KRYS) is one of the champion gene-editing stocks to bargain according to hedge funds. On November 5, Evercore ISI’s Gavin Clark-Gartner affirmed a Buy standing connected Krystal Biotech, Inc. (NASDAQ:KRYS) banal and acceptable a terms people of $218.

In a antithetic update, Krystal released its Q3 2025 results connected November 3, successful which the quarter’s EPS came successful astatine $2.66 per diluted stock against the anticipated $1.09. Revenue touched $97.8 cardinal from its VYJUVEK product, bringing full gross since the US motorboat to implicit $623 million. The quarter’s nett income was $79.4 million. According to management, this maturation was driven by manufacturing efficiencies and a one-time non-cash taxation benefit. Also, gross borderline improved to 96% during the quarter, up from 93% successful the anterior 4th owed to US merchandise manufacturing optimizations, arsenic noted by management. As a result, the institution ended the 4th with implicit $864 cardinal successful currency and investments.

In presumption of operations, absorption emphasized that enlargement into Germany, France, and Japan is underway. There are besides partnerships successful the Middle East, Turkey, and Central and Eastern Europe. The institution besides confirmed its ongoing absorption connected expanding diligent entree for the attraction of Dystrophic Epidermolysis Bullosa (DEB) and expanding its planetary marketplace presence.

Krystal Biotech, Inc. (NASDAQ:KRYS) is simply a biotechnology company. It develops and commercializes redosable cistron therapies for uncommon and superior familial diseases. Its archetypal approved product, VYJUVEK, is the lone FDA-approved redosable cistron therapy for DEB, a terrible tegument disorder.

While we admit the imaginable of KRYS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best European Bank Stocks to Buy Now and 11 Best Solar Energy Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.